World Courier Receives Wholesale Distribution Authorisation
World Courier, an AmerisourceBergen company, has been granted Wholesale Distribution Authorisation (WDA) by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The WDA is a benchmark certifying the company’s quality systems and processes for storing and distributing pharmaceuticals.
World Courier received the WDA certification following an application process and inspection by MHRA. Designed to ensure patients safely receive their proper medications, the regulation serves as a verification measure to enforce the European Union’s Falsified Medicine Directive. MHRA regulations require WDA for companies that store shipments of pharmaceutical products for longer than 36 hours or have a refrigerated storage facility for pharmaceuticals. The company also met requirements to demonstrate compliance with the European Union’s Good Distribution Practice (GDP), guidelines that regulate the storage and transportation of medicinal products intended for human consumption.
“Becoming one of the first specialty logistics companies to acquire Wholesale Distribution Authorisation in the UK is a significant accomplishment for AmerisourceBergen, World Courier and our clients,” said Simon Beaumont, Managing Director for World Courier in the UK. “As the global leader in specialty logistics, we continuously strive to offer our clients the best possible integrated supply chain services to improve the quality and accountability in the transportation, dispensing and storage of pharmaceutical products. The WDA accreditation recognises these efforts and demonstrates our commitment to a safe, secure and efficient specialty pharmaceutical supply chain.”
With World Courier receiving WDA accreditation, shipments of pharmaceuticals to the company’s UK location can be stored in MHRA-approved temperature controlled areas over extended periods of time, such as a weekend. Clients can rely on World Courier to be compliant with the MHRA requirements including equipment, documentation and qualified sub-contractors. Additionally, the supply chain’s security is improved by enhanced security and traceability of the shipments, as per MHRA standards.
The WDA accreditation is one way AmerisourceBergen continues to connect patients to vital treatments when and where they need them. Safe and timely delivery of medication is critical to the success of clinical trials and to patients accessing licensed medicinal products.
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance